COVID-19疫苗接种与月经健康的关系:基于经期跟踪应用程序的队列研究

IF 2.7 Q3 IMMUNOLOGY Vaccine: X Pub Date : 2024-05-18 DOI:10.1016/j.jvacx.2024.100501
Malini Ramaiyer , Malak El Sabeh , Jiafeng Zhu , Amanda Shea , Dorry Segev , Gayane Yenokyan , Mostafa A. Borahay
{"title":"COVID-19疫苗接种与月经健康的关系:基于经期跟踪应用程序的队列研究","authors":"Malini Ramaiyer ,&nbsp;Malak El Sabeh ,&nbsp;Jiafeng Zhu ,&nbsp;Amanda Shea ,&nbsp;Dorry Segev ,&nbsp;Gayane Yenokyan ,&nbsp;Mostafa A. Borahay","doi":"10.1016/j.jvacx.2024.100501","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>In initial COVID-19 clinical trials, menstrual health was not formally monitored, yet anecdotal reports of menstruation changes surfaced on social media. This study aims to assess the association between COVID-19 vaccines and menstruation using Clue, a period-tracking application.</p></div><div><h3>Study design</h3><p>A survey assessing demographics, menstrual health, stress levels, and COVID-19 vaccination was sent to Clue users between 12/7/2021 and 2/9/2022. Inclusion criteria were (1) 18 years or older (2) currently menstruating (3) not pregnant or breastfeeding since 1/2020. Menstrual data was collected for each participant. Users with cycle lengths more than 90 days were excluded. Cycle lengths were calculated for the 6-month average pre-vaccination (PRIOR), the cycle during which vaccination was administered (DURING), the cycle following DURING (AFTER1), and the cycle following AFTER1 (AFTER2). For periods, individuals were stratified based on whether vaccination was received during their menstrual period (DURING). Period lengths were additionally calculated for the 6-month average pre-vaccination (PRIOR), the first period following vaccination (AFTER1), and the period following AFTER1 (AFTER2). For unvaccinated participants, an index date (4/1/2022) was used to similarly designate menstrual cycles and periods. For each participant, cycle length changes for DURING, AFTER1, and AFTER2 compared to PRIOR were determined. Student’s <em>t</em>-test compared the mean of these changes between vaccinated and unvaccinated groups.</p></div><div><h3>Results</h3><p>Of 7,559 participants, 6,897 (91 %) were vaccinated. Compared to PRIOR, individuals vaccinated during their menstrual period demonstrated a statistically significant increase in the DURING period length, but not AFTER1 (p = 0.463) and AFTER2 (p = 0.692). No statistically significant changes were observed in period lengths of those vaccinated in between periods or in cycle lengths overall.</p></div><div><h3>Conclusion</h3><p>A small but statistically significant change in period length was observed only in individuals vaccinated for COVID-19 during their menstrual period. Providers can better counsel menstruating individuals to reduce vaccine misinformation.</p></div>","PeriodicalId":43021,"journal":{"name":"Vaccine: X","volume":"19 ","pages":"Article 100501"},"PeriodicalIF":2.7000,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590136224000743/pdfft?md5=16d8784a1f8b1675c3a6528fcb90d634&pid=1-s2.0-S2590136224000743-main.pdf","citationCount":"0","resultStr":"{\"title\":\"The association of COVID-19 vaccination and menstrual health: A period-tracking app-based cohort study\",\"authors\":\"Malini Ramaiyer ,&nbsp;Malak El Sabeh ,&nbsp;Jiafeng Zhu ,&nbsp;Amanda Shea ,&nbsp;Dorry Segev ,&nbsp;Gayane Yenokyan ,&nbsp;Mostafa A. Borahay\",\"doi\":\"10.1016/j.jvacx.2024.100501\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>In initial COVID-19 clinical trials, menstrual health was not formally monitored, yet anecdotal reports of menstruation changes surfaced on social media. This study aims to assess the association between COVID-19 vaccines and menstruation using Clue, a period-tracking application.</p></div><div><h3>Study design</h3><p>A survey assessing demographics, menstrual health, stress levels, and COVID-19 vaccination was sent to Clue users between 12/7/2021 and 2/9/2022. Inclusion criteria were (1) 18 years or older (2) currently menstruating (3) not pregnant or breastfeeding since 1/2020. Menstrual data was collected for each participant. Users with cycle lengths more than 90 days were excluded. Cycle lengths were calculated for the 6-month average pre-vaccination (PRIOR), the cycle during which vaccination was administered (DURING), the cycle following DURING (AFTER1), and the cycle following AFTER1 (AFTER2). For periods, individuals were stratified based on whether vaccination was received during their menstrual period (DURING). Period lengths were additionally calculated for the 6-month average pre-vaccination (PRIOR), the first period following vaccination (AFTER1), and the period following AFTER1 (AFTER2). For unvaccinated participants, an index date (4/1/2022) was used to similarly designate menstrual cycles and periods. For each participant, cycle length changes for DURING, AFTER1, and AFTER2 compared to PRIOR were determined. Student’s <em>t</em>-test compared the mean of these changes between vaccinated and unvaccinated groups.</p></div><div><h3>Results</h3><p>Of 7,559 participants, 6,897 (91 %) were vaccinated. Compared to PRIOR, individuals vaccinated during their menstrual period demonstrated a statistically significant increase in the DURING period length, but not AFTER1 (p = 0.463) and AFTER2 (p = 0.692). No statistically significant changes were observed in period lengths of those vaccinated in between periods or in cycle lengths overall.</p></div><div><h3>Conclusion</h3><p>A small but statistically significant change in period length was observed only in individuals vaccinated for COVID-19 during their menstrual period. Providers can better counsel menstruating individuals to reduce vaccine misinformation.</p></div>\",\"PeriodicalId\":43021,\"journal\":{\"name\":\"Vaccine: X\",\"volume\":\"19 \",\"pages\":\"Article 100501\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590136224000743/pdfft?md5=16d8784a1f8b1675c3a6528fcb90d634&pid=1-s2.0-S2590136224000743-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine: X\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590136224000743\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590136224000743","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

研究背景在最初的 COVID-19 临床试验中,月经健康并未受到正式监测,但社交媒体上出现了有关月经变化的传闻。研究设计在 2021 年 7 月 12 日至 2022 年 9 月 2 日期间向 Clue 用户发送了一项调查,评估人口统计学、月经健康、压力水平和 COVID-19 疫苗接种情况。纳入标准为:(1)18 岁或以上(2)目前有月经(3)自 2020 年 1 月以来未怀孕或哺乳。收集每位参与者的月经数据。月经周期超过 90 天的用户将被排除在外。计算的周期长度包括接种疫苗前 6 个月的平均周期(接种前)、接种疫苗期间的周期(接种期间)、接种期间之后的周期(接种后 1)以及接种后 1 之后的周期(接种后 2)。对于月经期,根据接种疫苗是否在月经期(DURING)对个体进行分层。此外,还计算了接种前 6 个月平均周期(PRIOR)、接种后第一个周期(AFTER1)和 AFTER1 之后的周期(AFTER2)的周期长度。对于未接种疫苗的受试者,同样使用指数日期(4/1/2022)来指定月经周期和月经期。对于每位参与者,都要确定 "DURING"、"AFTER1 "和 "AFTER2 "与 "PRIOR "相比的周期长度变化。结果 在 7559 名参与者中,有 6897 人(91%)接种了疫苗。与接种前相比,在经期接种疫苗的人在经期长度上有显著的统计学增长,但在经期1(p = 0.463)和经期2(p = 0.692)则没有。结论 仅在月经期接种 COVID-19 疫苗的人群中,月经期长度发生了微小但有统计学意义的变化。医疗服务提供者可以更好地为经期接种者提供咨询,以减少疫苗误导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The association of COVID-19 vaccination and menstrual health: A period-tracking app-based cohort study

Background

In initial COVID-19 clinical trials, menstrual health was not formally monitored, yet anecdotal reports of menstruation changes surfaced on social media. This study aims to assess the association between COVID-19 vaccines and menstruation using Clue, a period-tracking application.

Study design

A survey assessing demographics, menstrual health, stress levels, and COVID-19 vaccination was sent to Clue users between 12/7/2021 and 2/9/2022. Inclusion criteria were (1) 18 years or older (2) currently menstruating (3) not pregnant or breastfeeding since 1/2020. Menstrual data was collected for each participant. Users with cycle lengths more than 90 days were excluded. Cycle lengths were calculated for the 6-month average pre-vaccination (PRIOR), the cycle during which vaccination was administered (DURING), the cycle following DURING (AFTER1), and the cycle following AFTER1 (AFTER2). For periods, individuals were stratified based on whether vaccination was received during their menstrual period (DURING). Period lengths were additionally calculated for the 6-month average pre-vaccination (PRIOR), the first period following vaccination (AFTER1), and the period following AFTER1 (AFTER2). For unvaccinated participants, an index date (4/1/2022) was used to similarly designate menstrual cycles and periods. For each participant, cycle length changes for DURING, AFTER1, and AFTER2 compared to PRIOR were determined. Student’s t-test compared the mean of these changes between vaccinated and unvaccinated groups.

Results

Of 7,559 participants, 6,897 (91 %) were vaccinated. Compared to PRIOR, individuals vaccinated during their menstrual period demonstrated a statistically significant increase in the DURING period length, but not AFTER1 (p = 0.463) and AFTER2 (p = 0.692). No statistically significant changes were observed in period lengths of those vaccinated in between periods or in cycle lengths overall.

Conclusion

A small but statistically significant change in period length was observed only in individuals vaccinated for COVID-19 during their menstrual period. Providers can better counsel menstruating individuals to reduce vaccine misinformation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vaccine: X
Vaccine: X Multiple-
CiteScore
2.80
自引率
2.60%
发文量
102
审稿时长
13 weeks
期刊最新文献
HPV vaccine hesitancy among parents and caregivers of adolescents in Northern Nigeria Immunogenicities of vaccines including the immunoglobulin M-degrading enzyme of Streptococcus suis, rIdeSsuis, and protective efficacy against serotype 14 in piglets The importance of quality of health campaign information for outcome evaluation. A case study from Guinea-Bissau and Bangladesh Mumps outbreak in Zimbabwe: The case for universal MMR vaccination in Africa The clinical and economic value of enhanced influenza vaccines for the elderly in Argentina
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1